A proof-of-concept phase 2 study of monoclonal antibody MDX-33 in adult subjects with chronic stable ITP.

被引：0
|
作者：
Terjanian, T
Sher, H
Vemuri, R
Windsor, K
Nicolay, U
Vessey, A
Deo, Y
Curnow, R
机构：
[1] Staten Island Univ Hosp, Staten Isl, NY USA
[2] Jacksonville Oncol Grp, Jacksonville, FL USA
[3] W Michigan Canc Ctr, Kalamazoo, MI USA
[4] Birmingham Hematol Oncol Assoc, Birmingham, AL USA
[5] Aventis Behring, King Of Prussia, PA USA
[6] Medarex Inc, Annandale, NJ USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1081
引用
收藏
页码：251A / 251A
页数：1
相关论文
共 50 条
  • [21] Treatment with the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment: a proof-of-concept study-The PRO-ART study protocol
    Tidemandsen, Casper
    Gade, Elisabeth Juul
    Ulrik, Charlotte Suppli
    Nielsen, Henriette Svarre
    Oxlund-Mariegaard, Birgitte Sophie
    Kristiansen, Karsten
    Freiesleben, Nina La Cour
    Nohr, Bugge
    Udengaard, Hanne
    Backer, Vibeke
    BMJ OPEN, 2020, 10 (11):
  • [22] Crisaborole Topical Ointment, 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept Study
    Murrell, Dedee F.
    Gebauer, Kurt
    Spelman, Lynda
    Zane, Lee T.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (10) : 1108 - 1112
  • [23] Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy
    Smolen, Josef S.
    Weinblatt, Michael E.
    Sheng, Shihong
    Zhuang, Yanli
    Hsu, Benjamin
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (09) : 1616 - 1625
  • [24] Cizolirtine Citrate Is Safe and Effective for Treating Urinary Incontinence Secondary to Overactive Bladder: A Phase 2 Proof-of-Concept Study
    Zat'ura, Frantisek
    Vsetica, Jaroslav
    Abadias, Montserrat
    Pavlik, Ivan
    Schraml, Peter
    Brod'ak, Milos
    Villoria, Jesus
    Sust, Maria
    EUROPEAN UROLOGY, 2010, 57 (01) : 145 - 152
  • [25] US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
    Finberg, Robert W.
    Ashraf, Madiha
    Julg, Boris
    Ayoade, Folusakin
    Marathe, Jai G.
    Issa, Nicolas C.
    Wang, Jennifer P.
    Jaijakul, Siraya
    Baden, Lindsey R.
    Epstein, Carol
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (12):
  • [26] Rationale and design of a proof-of-concept phase II clinical study of E1224, a new drug candidate for chronic chagas disease
    Torrico, F.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 21 - 22
  • [27] Task-specific training for improving propulsion symmetry and gait speed in people in the chronic phase after stroke: a proof-of-concept study
    Alingh, J. F.
    Groen, B. E.
    Kamphuis, J. F.
    Geurts, A. C. H.
    Weerdesteyn, V.
    JOURNAL OF NEUROENGINEERING AND REHABILITATION, 2021, 18 (01)
  • [28] Task-specific training for improving propulsion symmetry and gait speed in people in the chronic phase after stroke: a proof-of-concept study
    J. F. Alingh
    B. E. Groen
    J. F. Kamphuis
    A. C. H. Geurts
    V. Weerdesteyn
    Journal of NeuroEngineering and Rehabilitation, 18
  • [29] A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
    Torrico, Faustino
    Gascon, Joaquim
    Ortiz, Lourdes
    Pinto, Jimy
    Rojas, Gimena
    Palacios, Alejandro
    Barreira, Fabiana
    Blum, Bethania
    Schijman, Alejandro Gabriel
    Vaillant, Michel
    Strub-Wourgaft, Nathalie
    Pinazo, Maria Jesus
    Bilbe, Graeme
    Ribeiro, Isabela
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1186 - E1194
  • [30] Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study
    Boumans, M. J. H.
    Houbiers, J. G. A.
    Verschueren, P.
    Ishikura, H.
    Westhovens, R.
    Brouwer, E.
    Rojkovich, B.
    Kelly, S.
    den Adel, M.
    Isaacs, J.
    Jacobs, H.
    Gomez-Reino, J.
    Holtkamp, G. M.
    Hastings, A.
    Gerlag, D. M.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (02) : 180 - 185
12345